nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS1—esophageal cancer	0.467	0.636	CbGaD
Diflunisal—PTGS2—esophageal cancer	0.267	0.364	CbGaD
Diflunisal—PTGS2—Cisplatin—esophageal cancer	0.0738	0.529	CbGbCtD
Diflunisal—SLC22A6—Methotrexate—esophageal cancer	0.0355	0.254	CbGbCtD
Diflunisal—ALB—Methotrexate—esophageal cancer	0.0302	0.217	CbGbCtD
Diflunisal—Gastrointestinal perforation—Capecitabine—esophageal cancer	0.00218	0.0554	CcSEcCtD
Diflunisal—Allergic cutaneous angiitis—Methotrexate—esophageal cancer	0.00133	0.0339	CcSEcCtD
Diflunisal—Olsalazine—PTGS1—esophageal cancer	0.000897	0.136	CrCbGaD
Diflunisal—Leukocytoclastic vasculitis—Methotrexate—esophageal cancer	0.000862	0.022	CcSEcCtD
Diflunisal—Aminosalicylic Acid—PTGS1—esophageal cancer	0.000843	0.128	CrCbGaD
Diflunisal—Hearing impaired—Cisplatin—esophageal cancer	0.000809	0.0206	CcSEcCtD
Diflunisal—Salsalate—PTGS1—esophageal cancer	0.000762	0.116	CrCbGaD
Diflunisal—Body temperature increased—Carboplatin—esophageal cancer	0.000741	0.0189	CcSEcCtD
Diflunisal—Mesalazine—PTGS1—esophageal cancer	0.000661	0.1	CrCbGaD
Diflunisal—Proteinuria—Capecitabine—esophageal cancer	0.000646	0.0165	CcSEcCtD
Diflunisal—Protein urine present—Capecitabine—esophageal cancer	0.000637	0.0162	CcSEcCtD
Diflunisal—Deafness—Cisplatin—esophageal cancer	0.000625	0.0159	CcSEcCtD
Diflunisal—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000619	0.0158	CcSEcCtD
Diflunisal—Hearing impaired—Capecitabine—esophageal cancer	0.000596	0.0152	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000559	0.0143	CcSEcCtD
Diflunisal—Olsalazine—PTGS2—esophageal cancer	0.000513	0.0779	CrCbGaD
Diflunisal—Cramp muscle—Cisplatin—esophageal cancer	0.000503	0.0128	CcSEcCtD
Diflunisal—Aminosalicylic Acid—PTGS2—esophageal cancer	0.000482	0.0732	CrCbGaD
Diflunisal—Proteinuria—Methotrexate—esophageal cancer	0.000481	0.0123	CcSEcCtD
Diflunisal—Protein urine present—Methotrexate—esophageal cancer	0.000474	0.0121	CcSEcCtD
Diflunisal—Photosensitivity—Capecitabine—esophageal cancer	0.000469	0.012	CcSEcCtD
Diflunisal—Salicylic acid—PTGS1—esophageal cancer	0.000469	0.0712	CrCbGaD
Diflunisal—Deafness—Capecitabine—esophageal cancer	0.000461	0.0117	CcSEcCtD
Diflunisal—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000457	0.0116	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000437	0.0111	CcSEcCtD
Diflunisal—Salsalate—PTGS2—esophageal cancer	0.000436	0.0662	CrCbGaD
Diflunisal—Renal impairment—Capecitabine—esophageal cancer	0.000433	0.011	CcSEcCtD
Diflunisal—Renal failure—Cisplatin—esophageal cancer	0.000424	0.0108	CcSEcCtD
Diflunisal—Stomatitis—Cisplatin—esophageal cancer	0.00042	0.0107	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000412	0.0105	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS1—esophageal cancer	0.000411	0.0624	CrCbGaD
Diflunisal—Mesalazine—PTGS2—esophageal cancer	0.000378	0.0574	CrCbGaD
Diflunisal—Visual impairment—Cisplatin—esophageal cancer	0.000373	0.0095	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000371	0.00946	CcSEcCtD
Diflunisal—Gastritis—Capecitabine—esophageal cancer	0.000365	0.0093	CcSEcCtD
Diflunisal—Tinnitus—Cisplatin—esophageal cancer	0.000361	0.00919	CcSEcCtD
Diflunisal—Flushing—Cisplatin—esophageal cancer	0.000359	0.00915	CcSEcCtD
Diflunisal—Bronchospasm—Capecitabine—esophageal cancer	0.00035	0.00893	CcSEcCtD
Diflunisal—Photosensitivity—Methotrexate—esophageal cancer	0.000349	0.00891	CcSEcCtD
Diflunisal—Dysuria—Capecitabine—esophageal cancer	0.000333	0.00849	CcSEcCtD
Diflunisal—Flatulence—Cisplatin—esophageal cancer	0.000332	0.00846	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000325	0.00829	CcSEcCtD
Diflunisal—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000325	0.00829	CcSEcCtD
Diflunisal—Visual disturbance—Methotrexate—esophageal cancer	0.000324	0.00825	CcSEcCtD
Diflunisal—Muscle spasms—Cisplatin—esophageal cancer	0.000324	0.00825	CcSEcCtD
Diflunisal—Vision blurred—Cisplatin—esophageal cancer	0.000317	0.00809	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000315	0.00803	CcSEcCtD
Diflunisal—Renal failure—Capecitabine—esophageal cancer	0.000312	0.00796	CcSEcCtD
Diflunisal—Stomatitis—Capecitabine—esophageal cancer	0.00031	0.00789	CcSEcCtD
Diflunisal—Jaundice—Capecitabine—esophageal cancer	0.00031	0.00789	CcSEcCtD
Diflunisal—Haematuria—Capecitabine—esophageal cancer	0.000303	0.00772	CcSEcCtD
Diflunisal—Agranulocytosis—Capecitabine—esophageal cancer	0.000296	0.00755	CcSEcCtD
Diflunisal—Hepatitis—Capecitabine—esophageal cancer	0.000285	0.00727	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000276	0.00704	CcSEcCtD
Diflunisal—Anaphylactic shock—Cisplatin—esophageal cancer	0.000275	0.007	CcSEcCtD
Diflunisal—Oedema—Cisplatin—esophageal cancer	0.000275	0.007	CcSEcCtD
Diflunisal—Visual impairment—Capecitabine—esophageal cancer	0.000275	0.007	CcSEcCtD
Diflunisal—Erythema multiforme—Capecitabine—esophageal cancer	0.00027	0.00687	CcSEcCtD
Diflunisal—Thrombocytopenia—Cisplatin—esophageal cancer	0.000269	0.00686	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—esophageal cancer	0.000268	0.0407	CrCbGaD
Diflunisal—Tinnitus—Capecitabine—esophageal cancer	0.000266	0.00678	CcSEcCtD
Diflunisal—Hyperhidrosis—Cisplatin—esophageal cancer	0.000266	0.00677	CcSEcCtD
Diflunisal—Flushing—Capecitabine—esophageal cancer	0.000265	0.00674	CcSEcCtD
Diflunisal—Anorexia—Cisplatin—esophageal cancer	0.000262	0.00668	CcSEcCtD
Diflunisal—Dysuria—Methotrexate—esophageal cancer	0.000248	0.00632	CcSEcCtD
Diflunisal—Paraesthesia—Cisplatin—esophageal cancer	0.000247	0.00629	CcSEcCtD
Diflunisal—Dyspnoea—Cisplatin—esophageal cancer	0.000245	0.00624	CcSEcCtD
Diflunisal—Flatulence—Capecitabine—esophageal cancer	0.000245	0.00623	CcSEcCtD
Diflunisal—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000242	0.00617	CcSEcCtD
Diflunisal—Decreased appetite—Cisplatin—esophageal cancer	0.000239	0.00609	CcSEcCtD
Diflunisal—Muscle spasms—Capecitabine—esophageal cancer	0.000239	0.00608	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—esophageal cancer	0.000235	0.0357	CrCbGaD
Diflunisal—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000234	0.00597	CcSEcCtD
Diflunisal—Vision blurred—Capecitabine—esophageal cancer	0.000234	0.00596	CcSEcCtD
Diflunisal—Renal failure—Methotrexate—esophageal cancer	0.000232	0.00592	CcSEcCtD
Diflunisal—Stomatitis—Methotrexate—esophageal cancer	0.00023	0.00587	CcSEcCtD
Diflunisal—Salicylic acid—ABCB1—esophageal cancer	0.000228	0.0346	CrCbGaD
Diflunisal—Sweating—Methotrexate—esophageal cancer	0.000227	0.00578	CcSEcCtD
Diflunisal—Feeling abnormal—Cisplatin—esophageal cancer	0.000226	0.00577	CcSEcCtD
Diflunisal—Haematuria—Methotrexate—esophageal cancer	0.000225	0.00575	CcSEcCtD
Diflunisal—Vertigo—Capecitabine—esophageal cancer	0.000223	0.00568	CcSEcCtD
Diflunisal—Syncope—Capecitabine—esophageal cancer	0.000223	0.00567	CcSEcCtD
Diflunisal—Agranulocytosis—Methotrexate—esophageal cancer	0.000221	0.00562	CcSEcCtD
Diflunisal—Palpitations—Capecitabine—esophageal cancer	0.000219	0.00559	CcSEcCtD
Diflunisal—Loss of consciousness—Capecitabine—esophageal cancer	0.000218	0.00556	CcSEcCtD
Diflunisal—Body temperature increased—Cisplatin—esophageal cancer	0.000217	0.00554	CcSEcCtD
Diflunisal—Hepatitis—Methotrexate—esophageal cancer	0.000212	0.00541	CcSEcCtD
Diflunisal—Chest pain—Capecitabine—esophageal cancer	0.000211	0.00539	CcSEcCtD
Diflunisal—Visual impairment—Methotrexate—esophageal cancer	0.000205	0.00521	CcSEcCtD
Diflunisal—Confusional state—Capecitabine—esophageal cancer	0.000204	0.00521	CcSEcCtD
Diflunisal—Oedema—Capecitabine—esophageal cancer	0.000203	0.00516	CcSEcCtD
Diflunisal—Hypersensitivity—Cisplatin—esophageal cancer	0.000202	0.00516	CcSEcCtD
Diflunisal—Erythema multiforme—Methotrexate—esophageal cancer	0.000201	0.00511	CcSEcCtD
Diflunisal—Shock—Capecitabine—esophageal cancer	0.000199	0.00508	CcSEcCtD
Diflunisal—Thrombocytopenia—Capecitabine—esophageal cancer	0.000198	0.00506	CcSEcCtD
Diflunisal—Tinnitus—Methotrexate—esophageal cancer	0.000198	0.00504	CcSEcCtD
Diflunisal—Asthenia—Cisplatin—esophageal cancer	0.000197	0.00503	CcSEcCtD
Diflunisal—Hyperhidrosis—Capecitabine—esophageal cancer	0.000196	0.00499	CcSEcCtD
Diflunisal—Anorexia—Capecitabine—esophageal cancer	0.000193	0.00492	CcSEcCtD
Diflunisal—Diarrhoea—Cisplatin—esophageal cancer	0.000188	0.00479	CcSEcCtD
Diflunisal—Insomnia—Capecitabine—esophageal cancer	0.000183	0.00467	CcSEcCtD
Diflunisal—Paraesthesia—Capecitabine—esophageal cancer	0.000182	0.00464	CcSEcCtD
Diflunisal—Dyspnoea—Capecitabine—esophageal cancer	0.000181	0.0046	CcSEcCtD
Diflunisal—Dyspepsia—Capecitabine—esophageal cancer	0.000178	0.00454	CcSEcCtD
Diflunisal—Decreased appetite—Capecitabine—esophageal cancer	0.000176	0.00449	CcSEcCtD
Diflunisal—Vomiting—Cisplatin—esophageal cancer	0.000175	0.00445	CcSEcCtD
Diflunisal—Fatigue—Capecitabine—esophageal cancer	0.000175	0.00445	CcSEcCtD
Diflunisal—Vision blurred—Methotrexate—esophageal cancer	0.000174	0.00444	CcSEcCtD
Diflunisal—Rash—Cisplatin—esophageal cancer	0.000173	0.00442	CcSEcCtD
Diflunisal—Constipation—Capecitabine—esophageal cancer	0.000173	0.00442	CcSEcCtD
Diflunisal—Dermatitis—Cisplatin—esophageal cancer	0.000173	0.00441	CcSEcCtD
Diflunisal—Feeling abnormal—Capecitabine—esophageal cancer	0.000167	0.00425	CcSEcCtD
Diflunisal—Vertigo—Methotrexate—esophageal cancer	0.000166	0.00423	CcSEcCtD
Diflunisal—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000166	0.00422	CcSEcCtD
Diflunisal—Nausea—Cisplatin—esophageal cancer	0.000163	0.00416	CcSEcCtD
Diflunisal—Urticaria—Capecitabine—esophageal cancer	0.000161	0.0041	CcSEcCtD
Diflunisal—Body temperature increased—Capecitabine—esophageal cancer	0.00016	0.00408	CcSEcCtD
Diflunisal—Chest pain—Methotrexate—esophageal cancer	0.000157	0.00401	CcSEcCtD
Diflunisal—Confusional state—Methotrexate—esophageal cancer	0.000152	0.00388	CcSEcCtD
Diflunisal—Anaphylactic shock—Methotrexate—esophageal cancer	0.000151	0.00384	CcSEcCtD
Diflunisal—Hypersensitivity—Capecitabine—esophageal cancer	0.000149	0.0038	CcSEcCtD
Diflunisal—Thrombocytopenia—Methotrexate—esophageal cancer	0.000148	0.00376	CcSEcCtD
Diflunisal—Hyperhidrosis—Methotrexate—esophageal cancer	0.000146	0.00372	CcSEcCtD
Diflunisal—Asthenia—Capecitabine—esophageal cancer	0.000145	0.0037	CcSEcCtD
Diflunisal—Anorexia—Methotrexate—esophageal cancer	0.000144	0.00366	CcSEcCtD
Diflunisal—Pruritus—Capecitabine—esophageal cancer	0.000143	0.00365	CcSEcCtD
Diflunisal—Diarrhoea—Capecitabine—esophageal cancer	0.000139	0.00353	CcSEcCtD
Diflunisal—Insomnia—Methotrexate—esophageal cancer	0.000136	0.00348	CcSEcCtD
Diflunisal—Paraesthesia—Methotrexate—esophageal cancer	0.000135	0.00345	CcSEcCtD
Diflunisal—Dyspnoea—Methotrexate—esophageal cancer	0.000134	0.00343	CcSEcCtD
Diflunisal—Somnolence—Methotrexate—esophageal cancer	0.000134	0.00342	CcSEcCtD
Diflunisal—Dizziness—Capecitabine—esophageal cancer	0.000134	0.00341	CcSEcCtD
Diflunisal—Dyspepsia—Methotrexate—esophageal cancer	0.000133	0.00338	CcSEcCtD
Diflunisal—Decreased appetite—Methotrexate—esophageal cancer	0.000131	0.00334	CcSEcCtD
Diflunisal—Fatigue—Methotrexate—esophageal cancer	0.00013	0.00331	CcSEcCtD
Diflunisal—Vomiting—Capecitabine—esophageal cancer	0.000129	0.00328	CcSEcCtD
Diflunisal—Rash—Capecitabine—esophageal cancer	0.000128	0.00326	CcSEcCtD
Diflunisal—Dermatitis—Capecitabine—esophageal cancer	0.000128	0.00325	CcSEcCtD
Diflunisal—Headache—Capecitabine—esophageal cancer	0.000127	0.00323	CcSEcCtD
Diflunisal—Feeling abnormal—Methotrexate—esophageal cancer	0.000124	0.00317	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000123	0.00314	CcSEcCtD
Diflunisal—Nausea—Capecitabine—esophageal cancer	0.00012	0.00307	CcSEcCtD
Diflunisal—Urticaria—Methotrexate—esophageal cancer	0.00012	0.00305	CcSEcCtD
Diflunisal—Body temperature increased—Methotrexate—esophageal cancer	0.000119	0.00304	CcSEcCtD
Diflunisal—Hypersensitivity—Methotrexate—esophageal cancer	0.000111	0.00283	CcSEcCtD
Diflunisal—Asthenia—Methotrexate—esophageal cancer	0.000108	0.00276	CcSEcCtD
Diflunisal—Pruritus—Methotrexate—esophageal cancer	0.000107	0.00272	CcSEcCtD
Diflunisal—Diarrhoea—Methotrexate—esophageal cancer	0.000103	0.00263	CcSEcCtD
Diflunisal—Dizziness—Methotrexate—esophageal cancer	9.97e-05	0.00254	CcSEcCtD
Diflunisal—Vomiting—Methotrexate—esophageal cancer	9.59e-05	0.00244	CcSEcCtD
Diflunisal—Rash—Methotrexate—esophageal cancer	9.51e-05	0.00242	CcSEcCtD
Diflunisal—Dermatitis—Methotrexate—esophageal cancer	9.5e-05	0.00242	CcSEcCtD
Diflunisal—Headache—Methotrexate—esophageal cancer	9.45e-05	0.00241	CcSEcCtD
Diflunisal—Nausea—Methotrexate—esophageal cancer	8.96e-05	0.00228	CcSEcCtD
Diflunisal—UGT1A8—digestive system—esophageal cancer	8.15e-05	0.196	CbGeAlD
Diflunisal—TTR—Signaling Pathways—HIST1H2BM—esophageal cancer	8e-05	0.000998	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CCND1—esophageal cancer	7.95e-05	0.000992	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PDE4D—esophageal cancer	7.93e-05	0.00099	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	7.89e-05	0.000984	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.88e-05	0.000983	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—HMOX1—esophageal cancer	7.71e-05	0.000962	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CDKN1A—esophageal cancer	7.69e-05	0.00096	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	7.68e-05	0.000958	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GNG7—esophageal cancer	7.54e-05	0.000941	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ABCB1—esophageal cancer	7.4e-05	0.000924	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—EP300—esophageal cancer	7.32e-05	0.000913	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	7.28e-05	0.000908	CbGpPWpGaD
Diflunisal—TTR—neck—esophageal cancer	7.23e-05	0.174	CbGeAlD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	7.17e-05	0.000895	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—XIAP—esophageal cancer	7.07e-05	0.000882	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC52A3—esophageal cancer	7e-05	0.000874	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—BLVRB—esophageal cancer	7e-05	0.000874	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	6.94e-05	0.000866	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PFN1—esophageal cancer	6.93e-05	0.000864	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	6.86e-05	0.000856	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CTNNA1—esophageal cancer	6.68e-05	0.000834	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	6.66e-05	0.000831	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	6.66e-05	0.000831	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFBR2—esophageal cancer	6.66e-05	0.00083	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL2—esophageal cancer	6.65e-05	0.000829	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC52A3—esophageal cancer	6.64e-05	0.000828	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—MYC—esophageal cancer	6.38e-05	0.000796	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KMT2D—esophageal cancer	6.33e-05	0.00079	CbGpPWpGaD
Diflunisal—TTR—Disease—SMAD4—esophageal cancer	6.3e-05	0.000786	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	6.26e-05	0.000781	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PSME2—esophageal cancer	6.21e-05	0.000775	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PSME1—esophageal cancer	6.21e-05	0.000775	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ANXA1—esophageal cancer	6.18e-05	0.000771	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CCND1—esophageal cancer	6.06e-05	0.000756	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SST—esophageal cancer	6.01e-05	0.00075	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CA1—esophageal cancer	5.96e-05	0.000743	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC10A2—esophageal cancer	5.96e-05	0.000743	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GHRL—esophageal cancer	5.86e-05	0.000731	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOTCH3—esophageal cancer	5.86e-05	0.000731	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	5.8e-05	0.000724	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—FBXW7—esophageal cancer	5.76e-05	0.000719	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CFL1—esophageal cancer	5.61e-05	0.0007	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	5.6e-05	0.000698	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	5.57e-05	0.000695	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—BLVRB—esophageal cancer	5.56e-05	0.000694	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC52A3—esophageal cancer	5.56e-05	0.000694	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CA2—esophageal cancer	5.45e-05	0.00068	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.37e-05	0.00067	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.32e-05	0.000664	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—GNG7—esophageal cancer	5.29e-05	0.00066	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOTCH2—esophageal cancer	5.25e-05	0.000655	CbGpPWpGaD
Diflunisal—TTR—Disease—HIF1A—esophageal cancer	5.15e-05	0.000643	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.15e-05	0.000643	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TP53—esophageal cancer	5.14e-05	0.000641	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ADH7—esophageal cancer	5.06e-05	0.000632	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PLCE1—esophageal cancer	5.06e-05	0.000632	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.06e-05	0.000632	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.05e-05	0.00063	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.01e-05	0.000625	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.97e-05	0.00062	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CREBBP—esophageal cancer	4.95e-05	0.000617	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FKBP1A—esophageal cancer	4.91e-05	0.000613	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MYC—esophageal cancer	4.86e-05	0.000606	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	4.8e-05	0.000599	CbGpPWpGaD
Diflunisal—PTGS2—Disease—WIF1—esophageal cancer	4.8e-05	0.000599	CbGpPWpGaD
Diflunisal—PTGS2—Disease—DOCK2—esophageal cancer	4.8e-05	0.000599	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	4.75e-05	0.000593	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC10A2—esophageal cancer	4.73e-05	0.00059	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CA1—esophageal cancer	4.73e-05	0.00059	CbGpPWpGaD
Diflunisal—TTR—Disease—NOS2—esophageal cancer	4.69e-05	0.000585	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.67e-05	0.000582	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFBR2—esophageal cancer	4.66e-05	0.000581	CbGpPWpGaD
Diflunisal—TTR—Disease—NOTCH1—esophageal cancer	4.64e-05	0.000579	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.58e-05	0.000571	CbGpPWpGaD
Diflunisal—ALB—Metabolism—BLVRB—esophageal cancer	4.5e-05	0.000561	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC52A3—esophageal cancer	4.5e-05	0.000561	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ADH1B—esophageal cancer	4.44e-05	0.000554	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—NOS3—esophageal cancer	4.43e-05	0.000553	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CSNK1A1—esophageal cancer	4.43e-05	0.000553	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SMAD4—esophageal cancer	4.41e-05	0.00055	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CA2—esophageal cancer	4.32e-05	0.00054	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—HSPA5—esophageal cancer	4.31e-05	0.000538	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TYMP—esophageal cancer	4.24e-05	0.00053	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.23e-05	0.000527	CbGpPWpGaD
Diflunisal—TTR—Disease—CREBBP—esophageal cancer	4.21e-05	0.000525	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP26A1—esophageal cancer	4.13e-05	0.000515	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.12e-05	0.000514	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTGS2—esophageal cancer	4.05e-05	0.000506	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALOX15—esophageal cancer	4.02e-05	0.000502	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.02e-05	0.000502	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ADH7—esophageal cancer	4.02e-05	0.000502	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PLCE1—esophageal cancer	4.02e-05	0.000502	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	3.99e-05	0.000498	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.99e-05	0.000498	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.97e-05	0.000496	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TPI1—esophageal cancer	3.84e-05	0.000479	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTO1—esophageal cancer	3.84e-05	0.000479	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC10A2—esophageal cancer	3.83e-05	0.000477	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CA1—esophageal cancer	3.83e-05	0.000477	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.79e-05	0.000473	CbGpPWpGaD
Diflunisal—TTR—Disease—NOS3—esophageal cancer	3.77e-05	0.00047	CbGpPWpGaD
Diflunisal—TTR—digestive system—esophageal cancer	3.74e-05	0.0898	CbGeAlD
Diflunisal—PTGS2—Disease—ELMO1—esophageal cancer	3.72e-05	0.000464	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALDOB—esophageal cancer	3.68e-05	0.000459	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TPI1—esophageal cancer	3.64e-05	0.000454	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GSTO1—esophageal cancer	3.64e-05	0.000454	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HIF1A—esophageal cancer	3.61e-05	0.00045	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GAPDH—esophageal cancer	3.54e-05	0.000442	CbGpPWpGaD
Diflunisal—TTR—Disease—ERBB2—esophageal cancer	3.53e-05	0.00044	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ADH1B—esophageal cancer	3.53e-05	0.00044	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CRABP1—esophageal cancer	3.51e-05	0.000438	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CA2—esophageal cancer	3.5e-05	0.000437	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ALDOB—esophageal cancer	3.49e-05	0.000435	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KDR—esophageal cancer	3.45e-05	0.000431	CbGpPWpGaD
Diflunisal—TTR—Disease—PTGS2—esophageal cancer	3.45e-05	0.00043	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.44e-05	0.00043	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.42e-05	0.000427	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—EP300—esophageal cancer	3.37e-05	0.000421	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TYMP—esophageal cancer	3.37e-05	0.00042	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HIST1H2BM—esophageal cancer	3.36e-05	0.000419	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GAPDH—esophageal cancer	3.36e-05	0.000419	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GNG7—esophageal cancer	3.34e-05	0.000417	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.31e-05	0.000413	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP26A1—esophageal cancer	3.28e-05	0.000409	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PLCE1—esophageal cancer	3.25e-05	0.000406	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ADH7—esophageal cancer	3.25e-05	0.000406	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOTCH1—esophageal cancer	3.25e-05	0.000406	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.23e-05	0.000403	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.22e-05	0.000401	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALOX15—esophageal cancer	3.19e-05	0.000398	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ABL1—esophageal cancer	3.19e-05	0.000398	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALDH2—esophageal cancer	3.13e-05	0.00039	CbGpPWpGaD
Diflunisal—TTR—lung—esophageal cancer	3.13e-05	0.075	CbGeAlD
Diflunisal—PTGS2—Metabolism—GSTO1—esophageal cancer	3.05e-05	0.00038	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TPI1—esophageal cancer	3.05e-05	0.00038	CbGpPWpGaD
Diflunisal—TTR—Disease—CDKN1A—esophageal cancer	3.01e-05	0.000376	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTT1—esophageal cancer	2.98e-05	0.000371	CbGpPWpGaD
Diflunisal—PTGS2—Disease—XIAP—esophageal cancer	2.97e-05	0.00037	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CREBBP—esophageal cancer	2.95e-05	0.000368	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP2A6—esophageal cancer	2.94e-05	0.000367	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.93e-05	0.000366	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALDOB—esophageal cancer	2.92e-05	0.000364	CbGpPWpGaD
Diflunisal—TTR—Disease—EP300—esophageal cancer	2.87e-05	0.000358	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ADH1B—esophageal cancer	2.85e-05	0.000356	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GAPDH—esophageal cancer	2.81e-05	0.000351	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.81e-05	0.00035	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.79e-05	0.000348	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ENO1—esophageal cancer	2.79e-05	0.000348	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CRABP1—esophageal cancer	2.79e-05	0.000348	CbGpPWpGaD
Diflunisal—PTGS2—Disease—B2M—esophageal cancer	2.76e-05	0.000344	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PSME2—esophageal cancer	2.75e-05	0.000343	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PSME1—esophageal cancer	2.75e-05	0.000343	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TYMP—esophageal cancer	2.73e-05	0.00034	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.72e-05	0.000339	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.68e-05	0.000334	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP26A1—esophageal cancer	2.65e-05	0.000331	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GNG7—esophageal cancer	2.65e-05	0.000331	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ENO1—esophageal cancer	2.64e-05	0.00033	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOS3—esophageal cancer	2.64e-05	0.000329	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PSME2—esophageal cancer	2.6e-05	0.000325	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PSME1—esophageal cancer	2.6e-05	0.000325	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ALOX15—esophageal cancer	2.58e-05	0.000322	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CALR—esophageal cancer	2.5e-05	0.000312	CbGpPWpGaD
Diflunisal—TTR—Disease—MYC—esophageal cancer	2.5e-05	0.000312	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CA—esophageal cancer	2.49e-05	0.000311	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALDH2—esophageal cancer	2.48e-05	0.00031	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ERBB2—esophageal cancer	2.47e-05	0.000308	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTO1—esophageal cancer	2.47e-05	0.000308	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TPI1—esophageal cancer	2.47e-05	0.000308	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—esophageal cancer	2.44e-05	0.000305	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FBXW7—esophageal cancer	2.42e-05	0.000302	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.4e-05	0.000299	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.37e-05	0.000296	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ALDOB—esophageal cancer	2.36e-05	0.000295	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTT1—esophageal cancer	2.36e-05	0.000295	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP2A6—esophageal cancer	2.34e-05	0.000291	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.33e-05	0.00029	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NOS2—esophageal cancer	2.3e-05	0.000287	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GAPDH—esophageal cancer	2.27e-05	0.000284	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CRABP1—esophageal cancer	2.25e-05	0.000281	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP19A1—esophageal cancer	2.23e-05	0.000278	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ENO1—esophageal cancer	2.21e-05	0.000276	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTGS1—esophageal cancer	2.21e-05	0.000276	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCND1—esophageal cancer	2.18e-05	0.000272	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PSME2—esophageal cancer	2.18e-05	0.000272	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PSME1—esophageal cancer	2.18e-05	0.000272	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GNG7—esophageal cancer	2.14e-05	0.000268	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CA—esophageal cancer	2.12e-05	0.000265	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1A—esophageal cancer	2.11e-05	0.000263	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CREBBP—esophageal cancer	2.07e-05	0.000258	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—HMOX1—esophageal cancer	2.03e-05	0.000254	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	2.02e-05	0.000252	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ALDH2—esophageal cancer	2.01e-05	0.000251	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EP300—esophageal cancer	2.01e-05	0.000251	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2e-05	0.000249	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFBR2—esophageal cancer	1.96e-05	0.000244	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ABCB1—esophageal cancer	1.95e-05	0.000244	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTT1—esophageal cancer	1.91e-05	0.000238	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP2A6—esophageal cancer	1.89e-05	0.000236	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP1B1—esophageal cancer	1.88e-05	0.000235	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.88e-05	0.000235	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SMAD4—esophageal cancer	1.85e-05	0.000231	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NOS3—esophageal cancer	1.85e-05	0.000231	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ENO1—esophageal cancer	1.79e-05	0.000223	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS1—esophageal cancer	1.79e-05	0.000223	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.79e-05	0.000223	CbGpPWpGaD
Diflunisal—PTGS1—epithelium—esophageal cancer	1.79e-05	0.0429	CbGeAlD
Diflunisal—PTGS2—Metabolism—CYP19A1—esophageal cancer	1.77e-05	0.000221	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PSME1—esophageal cancer	1.76e-05	0.00022	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PSME2—esophageal cancer	1.76e-05	0.00022	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—esophageal cancer	1.75e-05	0.000218	CbGpPWpGaD
Diflunisal—PTGS1—smooth muscle tissue—esophageal cancer	1.72e-05	0.0414	CbGeAlD
Diflunisal—TTR—Signaling Pathways—EGFR—esophageal cancer	1.71e-05	0.000214	CbGpPWpGaD
Diflunisal—PTGS2—epithelium—esophageal cancer	1.71e-05	0.041	CbGeAlD
Diflunisal—PTGS2—bronchus—esophageal cancer	1.68e-05	0.0404	CbGeAlD
Diflunisal—PTGS2—smooth muscle tissue—esophageal cancer	1.65e-05	0.0395	CbGeAlD
Diflunisal—PTGS2—Metabolism—HMOX1—esophageal cancer	1.61e-05	0.000201	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.58e-05	0.000198	CbGpPWpGaD
Diflunisal—PTGS1—trachea—esophageal cancer	1.58e-05	0.038	CbGeAlD
Diflunisal—PTGS2—Metabolism—ABCB1—esophageal cancer	1.55e-05	0.000193	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.54e-05	0.000192	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP1B1—esophageal cancer	1.52e-05	0.00019	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HIF1A—esophageal cancer	1.51e-05	0.000189	CbGpPWpGaD
Diflunisal—PTGS2—trachea—esophageal cancer	1.51e-05	0.0363	CbGeAlD
Diflunisal—TTR—Signaling Pathways—PIK3CA—esophageal cancer	1.49e-05	0.000185	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.48e-05	0.000184	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—esophageal cancer	1.44e-05	0.000179	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP19A1—esophageal cancer	1.43e-05	0.000179	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—EP300—esophageal cancer	1.41e-05	0.000176	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOS2—esophageal cancer	1.38e-05	0.000172	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOTCH1—esophageal cancer	1.36e-05	0.00017	CbGpPWpGaD
Diflunisal—ALB—lymph node—esophageal cancer	1.36e-05	0.0327	CbGeAlD
Diflunisal—PTGS1—digestive system—esophageal cancer	1.36e-05	0.0327	CbGeAlD
Diflunisal—ALB—Metabolism—HMOX1—esophageal cancer	1.31e-05	0.000163	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CREBBP—esophageal cancer	1.31e-05	0.000163	CbGpPWpGaD
Diflunisal—PTGS2—digestive system—esophageal cancer	1.3e-05	0.0312	CbGeAlD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.28e-05	0.00016	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ABCB1—esophageal cancer	1.25e-05	0.000156	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CREBBP—esophageal cancer	1.24e-05	0.000154	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.17e-05	0.000146	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NOS3—esophageal cancer	1.17e-05	0.000146	CbGpPWpGaD
Diflunisal—PTGS1—lung—esophageal cancer	1.14e-05	0.0273	CbGeAlD
Diflunisal—PTGS2—Disease—NOS3—esophageal cancer	1.11e-05	0.000138	CbGpPWpGaD
Diflunisal—PTGS2—lung—esophageal cancer	1.09e-05	0.0261	CbGeAlD
Diflunisal—PTGS1—Metabolism—PTGS2—esophageal cancer	1.07e-05	0.000133	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CA—esophageal cancer	1.04e-05	0.00013	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CREBBP—esophageal cancer	1.04e-05	0.000129	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB2—esophageal cancer	1.04e-05	0.000129	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—esophageal cancer	1.01e-05	0.000126	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.48e-06	0.000118	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NOS3—esophageal cancer	9.28e-06	0.000116	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—EP300—esophageal cancer	8.89e-06	0.000111	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1A—esophageal cancer	8.85e-06	0.00011	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EP300—esophageal cancer	8.42e-06	0.000105	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CREBBP—esophageal cancer	8.38e-06	0.000105	CbGpPWpGaD
Diflunisal—PTGS1—lymph node—esophageal cancer	7.77e-06	0.0187	CbGeAlD
Diflunisal—ALB—Metabolism—NOS3—esophageal cancer	7.5e-06	9.36e-05	CbGpPWpGaD
Diflunisal—PTGS2—lymph node—esophageal cancer	7.43e-06	0.0178	CbGeAlD
Diflunisal—PTGS2—Disease—MYC—esophageal cancer	7.34e-06	9.16e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—esophageal cancer	7.18e-06	8.96e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—EP300—esophageal cancer	7.06e-06	8.8e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—esophageal cancer	6.86e-06	8.56e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CA—esophageal cancer	6.57e-06	8.2e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CA—esophageal cancer	6.23e-06	7.78e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—EP300—esophageal cancer	5.71e-06	7.12e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CA—esophageal cancer	5.22e-06	6.51e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CA—esophageal cancer	4.22e-06	5.27e-05	CbGpPWpGaD
